A group of 31 Democratic senators has launched an investigation into a new Trump administration policy that they say allows the Environmental Protection Agency A group of 31 Democratic senators has launched an investigation into a new Trump administration policy that they say allows the Environmental Protection Agency

Dems Launch Investigation Into Trump EPA Policy to ‘Disregard’ Health Impacts of Pollution

2026/02/16 09:43
3 min read

A group of 31 Democratic senators has launched an investigation into a new Trump administration policy that they say allows the Environmental Protection Agency to “disregard” the health impacts of air pollution when passing regulations.

Plans for the policy were first reported on last month by the New York Times, which revealed that the EPA was planning to stop tallying the financial value of health benefits caused by limiting fine particulate matter (PM2.5) and ozone when regulating polluting industries and instead focus exclusively on the costs these regulations pose to industry.

On December 11, the Times reported that the policy change was being justified based on the claim that the exact benefits of curbing these emissions were “uncertain.”

“Historically, the EPA’s analytical practices often provided the public with false precision and confidence regarding the monetized impacts of fine particulate matter (PM2.5) and ozone,” said an email written by an EPA supervisor to his employees on December 11. “To rectify this error, the EPA is no longer monetizing benefits from PM2.5 and ozone.”

The group of senators, led by Sen. Sheldon Whitehouse (D-RI), rebuked this idea in a letter sent Thursday to EPA Administrator Lee Zeldin.

“EPA’s new policy is irrational. Even where health benefits are ‘uncertain,’ what is certain is that they are not zero,” they said. “It will lead to perverse outcomes in which EPA will reject actions that would impose relatively minor costs on polluting industries while resulting in massive benefits to public health—including in saved lives.”

“It is contrary to Congress’s intent and directive as spelled out in the Clean Air Act. It is legally flawed,” they continued. “The only beneficiaries will be polluting industries, many of which are among President [Donald] Trump’s largest donors.”

Research published in 2023 in the journal Science found that between 1999 and 2020, PM2.5 pollution from coal-fired power plants killed roughly 460,000 people in the United States, making it more than twice as deadly as other kinds of fine particulate emissions.

While this is a staggering loss of life, the senators pointed out that the EPA has also been able to put a dollar value on the loss by noting quantifiable results of increased illness and death—heightened healthcare costs, missed school days, and lost labor productivity, among others.

Pointing to EPA estimates from 2024, they said that by disregarding human health effects, the agency risks costing Americans “between $22 and $46 billion in avoided morbidities and premature deaths in the year 2032.”

Comparatively, they said, “the total compliance cost to industry, meanwhile, [would] be $590 million—between one and two one-hundredths of the estimated health benefit value.”

They said the plan ran counter to the Clean Air Act’s directive to “protect and enhance the quality of the Nation’s air resources so as to promote the public health and welfare,” and to statements made by Zeldin during his confirmation hearing, where he said “the end state of all the conversations that we might have, any regulations that might get passed, any laws that might get passed by Congress” is to “have the cleanest, healthiest air, [and] drinking water.”

The senators requested all documents related to the decision, including any information about cost-benefit modeling and communications with industry representatives.

“That EPA may no longer monetize health benefits when setting new clean air standards does not mean that those health benefits don’t exist,” the senators said. “It just means that [EPA] will ignore them and reject safer standards, in favor of protecting corporate interests.”

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.494
$3.494$3.494
+1.59%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

EUR/USD holds losses near 1.1850 as US, China holidays keep trade muted

EUR/USD holds losses near 1.1850 as US, China holidays keep trade muted

The post EUR/USD holds losses near 1.1850 as US, China holidays keep trade muted appeared on BitcoinEthereumNews.com. EUR/USD opens the week on a softer note, trading
Share
BitcoinEthereumNews2026/02/16 10:21
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
YZi Labs SEC Filing: Crucial Revised Consent for CEA Industry Signals Regulatory Progress

YZi Labs SEC Filing: Crucial Revised Consent for CEA Industry Signals Regulatory Progress

BitcoinWorld YZi Labs SEC Filing: Crucial Revised Consent for CEA Industry Signals Regulatory Progress In a significant development for cryptocurrency regulatory
Share
bitcoinworld2026/02/16 10:40